Skip to main content
. 2012 Jul 9;2012:648965. doi: 10.1155/2012/648965

Figure 1.

Figure 1

IGF-IR blockade reduces phosphorylation of HER2 in trastuzumab-resistant cells. SKBR3 cells with acquired resistance to trastuzumab were untreated or treated with 0.25 μg/mL alpha IR3 IGF-IR monoclonal antibody overnight. Total protein lysates were western blotted for phosphorylated and total HER2 and IGF-IR. Actin served as a loading control.